aspartic acid has been researched along with phenobarbital sodium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gafurov, B; Grossfeld, RM; Lieberman, EM; Urazaev, AK | 1 |
| Calvin, D; Rojas, C; Slusher, BS; Thomas, AG; Tsukamoto, T; Vornov, J; Wozniak, KM; Wu, Y | 1 |
| Alt, J; Hollinger, KR; Kaplin, AI; Riehm, AM; Slusher, BS | 1 |
1 review(s) available for aspartic acid and phenobarbital sodium
| Article | Year |
|---|---|
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
Topics: Analgesics; Animals; Aspartic Acid; Dipeptides; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Molecular Structure; Neurons; Neuroprotective Agents; Organophosphorus Compounds | 2006 |
2 other study(ies) available for aspartic acid and phenobarbital sodium
| Article | Year |
|---|---|
N-acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber.
Topics: Animals; Aspartic Acid; Astacoidea; Axons; Carboxypeptidases; Cell Communication; Cysteic Acid; Dipeptides; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Glutamic Acid; Membrane Potentials; N-Methylaspartate; Nervous System; Neuroglia; Organophosphorus Compounds; Receptors, Glutamate; Signal Transduction; Time Factors | 2001 |
Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis.
Topics: Animals; Aspartic Acid; Cognition Disorders; Dipeptides; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Glutamate Carboxypeptidase II; Hippocampus; Maze Learning; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Organophosphorus Compounds; Severity of Illness Index | 2016 |